Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study
Appelberg, B G, Syvälahti, E K, Koskinen, T E, Mehtonen, O P, Muhonen, T T, Naukkarinen, H H
Published in The journal of clinical psychiatry (01.06.2001)
Published in The journal of clinical psychiatry (01.06.2001)
Get more information
Journal Article